PLUS1
1,765.60
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Market Closed
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
Best deals to access real time data! |
|
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
$29.56
|
|
London Stock Exchange Level 2
Monthly Subscription
for only
$77.61
|
|
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
$88.69
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Gsk Plc | GSK | London | Ordinary Share |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 1,765.60 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1,765.60 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 4 | 0.00 | - | 1,362.80 - 1,817.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:18:39 | O | 130 | 1,770.50p | GBX |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
Period:
Draw Mode:
Gsk Plc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 89.76Bp | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Gsk News
Loading Messages....
Gsk Discussion Forums - GSK
| Date | Time | Comments | Title |
|---|---|---|---|
| 6/08/2022 | 00:58 | - | So, why shares aren''t realy mooning in pre-market? |
| 6/06/2022 | 09:02 | - | Complete Responses in 100% of dMMR Rectal Cancer |
| 6/05/2022 | 13:08 | - | Lete-Cel ASCO data https://www.cgtlive.com/view/lete-cel-exhibits-anti-tumor-act |
| 4/23/2022 | 12:20 | - | The company has updated the master protocol for |
| 12/05/2021 | 05:47 | - | [color=green] [t] GSK[/t] [/color] Should buy [color=red] [t] |
| 6/05/2021 | 08:24 | - | New NY-ESO-1 TCR-T data https://jitc.bmj.com/content/7/1/276 |
| 5/26/2021 | 16:48 | - | They have shared some preclinical data https://www.sec.gov/Archives/edgar/data/1 |
| 5/25/2021 | 16:04 | - | Preclinical data from another group: ''''Hepatocellular carcinoma (HCC) |
| 5/19/2021 | 17:55 | - | Some more info https://lyell.com/our-platforms |
| 5/01/2021 | 05:52 | - | GSK V TEVA question. The panel of judges |
Historical GSK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1,734.20 | 1,793.00 | 1,729.00 | 1,767.99 | 8,828,480 | 31.40 | 1.81% |
| 1 Month | 1,722.00 | 1,793.00 | 1,666.00 | 1,722.57 | 12,339,193 | 43.60 | 2.53% |
| 3 Months | 1,750.00 | 1,817.00 | 1,666.00 | 1,748.13 | 11,959,814 | 15.60 | 0.89% |
| 6 Months | 1,590.60 | 1,817.00 | 1,445.40 | 1,680.09 | 10,562,268 | 175.00 | 11.0% |
| 1 Year | 1,434.60 | 1,817.00 | 1,362.80 | 1,598.96 | 8,839,742 | 331.00 | 23.07% |
| 3 Years | 1,594.80 | 1,857.00 | 1,190.80 | 1,551.20 | 9,176,040 | 170.80 | 10.71% |
| 5 Years | 1,635.50 | 1,857.00 | 1,190.80 | 1,521.25 | 9,140,114 | 130.10 | 7.95% |
